HC Wainwright & Co. reiterated coverage on PDS Biotechnology with a new price target

3/19/21 6:45:05 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of PDS Biotechnology with a rating of Buy and set a new price target of $8.00 from $6.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PDSB

Date	Price Target	Rating	Analyst
11/1/2022	$10.00	Buy	B. Riley Securities
8/12/2021	$20.00 → $15.00	Buy	HC Wainwright & Co.
6/28/2021	$25.00	Overweight	Cantor Fitzgerald